State Ledger
Company profile

KALA BIO, Inc. CIK 1479419

Ticker
KALA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Arlington, MA 02476
Fiscal year end
2025 (FY)
Market Data
Close
$0.28
Change
-$0.01
Change %
-3.96%
Volume
13,341

KALA · trading date Oct 12, 2026 · previous close $0.29 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$26.98M
Total assets
$9.49M
Total liabilities
$2.49M
Stockholders' equity
$7.00M
Cash & equivalents
$7.56M
Operating income
-$39.16M
Operating cash flow
-$31.99M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-04-15. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
26.3%
Equity / assets
73.7%
CapEx / revenue
—
Operating cash flow / net income
1.19×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$26.98M $9.49M $2.49M $7.00M
2024 — -$38.51M $55.48M $43.15M $12.33M
2023 — -$42.20M $55.95M $48.45M $7.50M
2022 — -$44.82M $86.82M $67.85M $18.97M
2021 — -$142.61M $139.43M $122.62M $16.80M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form PRE 14A
2026-09-11
Financials filed via
Form 10-K
filed 2026-04-15

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Arlington, MA 02476
1167 MASSACHUSETTS AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies